Predictive modeling provides insight into the clinical heterogeneity associated with TARS1 loss-of-function mutations.
Meyer-Schuman R, Cale AR, Pierluissi JA, Jonatzke KE, Park YN, Lenk GM, Oprescu SN, Grachtchouk MA, Dlugosz AA, Beg AA, Meisler MH, Antonellis A.
Meyer-Schuman R, et al. Among authors: beg aa.
bioRxiv [Preprint]. 2024 Mar 27:2024.03.25.586600. doi: 10.1101/2024.03.25.586600.
bioRxiv. 2024.
PMID: 38585737
Free PMC article.
Preprint.